Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says
Botox maker Galderma sees early boost from 'Ozempic face' trend as GLP-1 use climbs, CEO says
The aestetics company hope increased GLP-1 use will fuel demand for treatments addressing facial volume loss, sometimes dubbed "Ozempic face."
Category: Finance
Source: https://www.cnbc.com/2026/07/23/botox-galderma-ozempic-face-glp1.html
Published by Viralsin AI News